Case File №
#VI-2026-0955
HealthTide Biotech
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
34 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | C Okay | 6 | 7.6 | 4.4 | 10.0 | 5 Aug 2025 |
| 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | X N/A | 1 | 7.0 | 7.0 | 7.0 | 17 Dec 2024 |
| Adipotide | X N/A | 1 | 9.8 | 9.8 | 9.8 | 27 Feb 2025 |
| Anadrol Oil | X N/A | 1 | 7.8 | 7.8 | 7.8 | 13 Feb 2025 |
| Andarine S4 | X N/A | 1 | 6.4 | 6.4 | 6.4 | 17 Dec 2024 |
| APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | X N/A | 1 | 6.9 | 6.9 | 6.9 | 20 Jun 2025 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 1 | 9.1 | 9.1 | 9.1 | 3 Jun 2025 |
| Botulinum toxin | X N/A | 1 | 8.8 | 8.8 | 8.8 | 13 Jun 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 8.1 | 8.1 | 8.1 | 25 Apr 2025 |
| Bronchogen | X N/A | 1 | 5.0 | 5.0 | 5.0 | 14 Jan 2025 |
| Cartalax | X N/A | 1 | 6.9 | 6.9 | 6.9 | 3 Jun 2025 |
| CJC-1295 With DAC | X N/A | 1 | 7.3 | 7.3 | 7.3 | 3 Jul 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 6.9 | 6.9 | 6.9 | 2 Jul 2025 |
| Clomiphene (Clomid) Raw | X N/A | 1 | 8.3 | 8.3 | 8.3 | 16 Mar 2025 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 5.5 | 5.5 | 5.5 | 13 Feb 2025 |
| EPO | X N/A | 1 | 7.8 | 7.8 | 7.8 | 14 Jan 2025 |
| Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | X N/A | 1 | 5.5 | 5.5 | 5.5 | 13 Jun 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 9.0 | 9.0 | 9.0 | 8 Jul 2025 |
| MGF | X N/A | 1 | 8.3 | 8.3 | 8.3 | 3 Jul 2025 |
| Minoxidil Oral | X N/A | 1 | 6.5 | 6.5 | 6.5 | 2 Jul 2025 |
| MOTS-C | X N/A | 1 | 5.9 | 5.9 | 5.9 | 9 Jun 2025 |
| P21 | X N/A | 1 | 9.4 | 9.4 | 9.4 | 13 Jun 2025 |
| Pinealon | X N/A | 1 | 6.5 | 6.5 | 6.5 | 9 Jun 2025 |
| PTD-DBM | X N/A | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 8.0 | 8.0 | 8.0 | 9 Jun 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 5.3 | 5.3 | 5.3 | 6 May 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 8.0 | 8.0 | 8.0 | 13 Jun 2025 |
| Selank | X N/A | 1 | 5.8 | 5.8 | 5.8 | 13 Feb 2025 |
| Semaglutide Oral | X N/A | 1 | 8.3 | 8.3 | 8.3 | 25 Apr 2025 |
| Tamoxifen (Nolvadex) | X N/A | 1 | 8.9 | 8.9 | 8.9 | 24 Apr 2025 |
| Test Suspension | X N/A | 1 | 5.4 | 5.4 | 5.4 | 13 Feb 2025 |
| Tren Hex | X N/A | 1 | 8.1 | 8.1 | 8.1 | 14 Jan 2025 |
| TriTren 225 | X N/A | 1 | 7.1 | 7.1 | 7.1 | 27 Feb 2025 |
| Vesugen | X N/A | 1 | 7.8 | 7.8 | 7.8 | 7 May 2025 |
Exhibit II
Evidence Log
39 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | DHB (1-Test Cyp) Oral | 4.6 C | 100mg | 110.0mg | +10.0% | 98.00% | 005c5t | Lab G | Community |
| 24 May 2026 | Selank | 5.5 B | 5mg | 4.4mg | -12.8% | 96.73% | oveq19 | Lab E | Public |
| 24 May 2026 | Clomiphene (Clomid) Raw | 6.4 A | 5g | 4.5g | -10.1% | 96.31% | a61xya | Lab G | Public |
| 24 May 2026 | Retatrutide 30mg Pen Kit | 9.3 A | 10mg | 9.2mg | -8.3% | 96.26% | ehvssc | Lab B | Community |
| 24 May 2026 | EPO | 7.1 A | 20mg | 18.9mg | -5.3% | 96.29% | 24u8r7 | Lab G | Community |
| 23 May 2026 | Tirzepatide | 10.0 A | 30mg | 31.3mg | +4.3% | 99.88% | TR30 | Lab E | Public |
| 23 May 2026 | Semaglutide Oral | 8.4 A | 100mg | 112.2mg | +12.2% | 99.04% | qsu311 | Lab C | Community |
| 23 May 2026 | Tren Hex | 6.3 A | 300mg/ml | 268.9mg/ml | -10.4% | 97.32% | 473nvf | Lab E | Community |
| 21 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.9 A | 10mg | 11.6mg | +16.1% | 97.45% | md2xmg | Lab A | Public |
| 21 May 2026 | Andarine S4 | 7.0 A | 25mg | 30.5mg | +21.9% | 96.48% | otgrx2 | Lab B | Community |
| 20 May 2026 | Blend 300 (TRA/Mast P/Test P) | 8.3 A | 250mg/ml | 287.1mg/ml | +14.8% | 97.34% | 69jhyt | Lab D | Community |
| 19 May 2026 | Test Suspension | 5.5 B | 300mg/ml | 357.9mg/ml | +19.3% | 95.87% | v47x55 | Lab B | Public |
| 17 May 2026 | Adipotide | 10.0 A | 50mg | 46.9mg | -6.2% | 95.45% | 738fsi | Lab E | Community |
| 17 May 2026 | Tamoxifen (Nolvadex) | 8.5 A | 20mg | 22.1mg | +10.6% | 99.17% | agcv3c | Lab C | Public |
| 26 Jan 2026 | BPC157 5mg + TB500 5mg Blend | 8.4 A | 50mg | 51.7mg | +3.5% | 98.20% | dxffqu | Lab E | Public |
| 26 Jan 2026 | Retatrutide 5mg + Cagrilintide 5mg Blend | 5.8 B | 10mg | 10.9mg | +9.4% | 99.91% | azut0s | Lab A | Public |
| 9 Jan 2026 | Bronchogen | 4.0 C | 2mg | 2.3mg | +15.8% | 96.43% | ylh1o6 | Lab B | Public |
| 7 Jan 2026 | Anadrol Oil | 8.3 A | 300mg/ml | 323.0mg/ml | +7.7% | 96.33% | t7qukr | Lab E | Public |
| 6 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 10.0 A | 2mg | 2.3mg | +13.0% | 97.22% | rjyyvq | Lab F | Public |
| 6 Jan 2026 | Pinealon | 4.6 C | 50mg | 55.5mg | +11.0% | 95.14% | k3nwrl | Lab E | Public |
| 29 Dec 2025 | 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | 6.7 A | 500g | 621.1g | +24.2% | 98.86% | s8gcnt | Lab A | Public |
| 29 Dec 2025 | MOTS-C | 7.0 A | 5mg | 5.4mg | +8.0% | 96.42% | 2hofwc | Lab A | Public |
| 17 Dec 2025 | Tirzepatide | 9.4 A | 10mg | 9.32mg | -6.8% | 99.95% | 11/24/2025 | Lab E | Public |
| 17 Nov 2025 | CJC-1295 With DAC | 7.5 A | 30mg | 28.5mg | -5.0% | 96.08% | lb6ffc | Lab E | Public |
| 14 Nov 2025 | Vesugen | 7.9 A | 10mg | 12.5mg | +24.9% | 96.15% | 9tump5 | Lab A | Public |
| 5 Nov 2025 | Cartalax | 6.3 A | 5mg | 4.9mg | -2.3% | 99.24% | v5m2iv | Lab F | Public |
| 5 Nov 2025 | TriTren 225 | 6.9 A | 250mg/ml | 250.7mg/ml | +0.3% | 98.25% | cju5qb | Lab F | Public |
| 4 Nov 2025 | Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | 4.0 C | 250mg/ml | 288.5mg/ml | +15.4% | 98.22% | upd9cb | Lab D | Public |
| 4 Nov 2025 | MGF | 7.9 A | 10mg | 9.0mg | -10.4% | 99.56% | jnb45x | Lab A | Public |
| 9 Oct 2025 | APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | 7.4 A | 5g | 6.0g | +20.7% | 98.83% | oeczm6 | Lab B | Public |
| 9 Oct 2025 | Botulinum toxin | 9.6 A | 2mg | 2.1mg | +4.4% | 96.59% | jzs4y0 | Lab C | Public |
| 9 Oct 2025 | P21 | 8.9 A | 2mg | 1.9mg | -2.5% | 95.97% | m5fv24 | Lab A | Community |
| 9 Oct 2025 | Selank 10mg + Semax 10mg Blend | 7.6 A | 2mg | 2.0mg | -0.2% | 95.24% | n65j6c | Lab A | Public |
| 3 Oct 2025 | Minoxidil Oral | 6.5 A | 50mg | 60.1mg | +20.2% | 98.00% | 85kb4l | Lab A | Public |
| 3 Oct 2025 | PTD-DBM | 9.3 A | 5mg | 5.6mg | +11.4% | 96.36% | hla3gx | Lab F | Public |
| 28 Aug 2025 | Tirzepatide | 8.0 A | 30mg | 29.3mg | -2.3% | 99.88% | (no batch ID) | Lab E | Public |
| 28 Aug 2025 | Tirzepatide | 8.0 A | 30mg | 29.2mg | -2.7% | 99.89% | (no batch ID) | Lab E | Public |
| 5 Aug 2025 | Tirzepatide | 4.4 D | 20mg | 16.9mg | -15.5% | 86.05% | Q368459261 | Lab E | Public |
| 5 Aug 2025 | Tirzepatide | 6.1 B | 20mg | 18.5mg | -7.5% | 92.03% | Q368459261 | Lab E | Public |
— END OF EVIDENCE LOG —